Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Very Early Onset Inflammatory Bowel Disease: Investigation of the Il-10 Signaling Pathway in Iranian Children Publisher Pubmed



Nemati S1 ; Teimourian S2, 3 ; Tabrizi M4 ; Najafi M5 ; Dara N6 ; Imanzadeh F6 ; Ahmadi M7 ; Aghdam MK8 ; Tavassoli M9 ; Rohani P6 ; Madani SR10 ; De Boer M11 ; Kuijpers TW11 ; Roos D11
Authors

Source: European Journal of Medical Genetics Published:2017


Abstract

Background & aim Comparing to adult inflammatory bowel disease (IBD), those with early onset manifestations have different features in terms of the underlying molecular pathology, the course of disease and the response to therapy. We investigated the IL-10 signaling pathway previously reported as an important cause of infantile (Very Early Onset) IBD to find any possible variants. Method With the next generation sequencing technique we screened IL-10, IL-10RA and IL10RB genes of 15 children affected by very early onset-GI (gastrointestinal) disorders. Additionally, we analyzed them based on Thermo Fisher immune deficiency panel for genes either having a known role in IBD pathogenesis or cause the disorders with overlapping manifestations. We performed multiple functional analyses only for the cases showing variants in IL-10- related genes. Result In 3 out of 15 patients we identified variants including a homozygous and heterozygote mutations in IL-10RA and a novel homozygous mutation in IL-12RB1. Our functional studies reveal that in contrast to the IL-10RA heterozygote mutation that does not have deleterious effects, the homozygous mutation abrogates the IL-10 signaling pathway. Conclusion Our study suggests we need to modify the classical diagnostic approach from functional assays followed by candidate- gene or genes sequencing to the firstly parallel genomic screening followed by functional studies. © 2017 Elsevier Masson SAS
Other Related Docs
11. Emerging Involvement of Long Non-Coding Rnas in Gastrointestinal Associated Inflammatory Disorders, Comparative Immunology, Microbiology and Infectious Diseases (2020)